Gene · 10468
Papers3,272
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,272
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cross-Platform Transcriptomic Analysis of 40 Human and Rodent Skeletal Muscle Exerkines. | Muscles | 2026 | 41718082 | PubTator, text mining | PubMed |
| A narrative review on the correlation between diabetic foot and sarcopenia. | Front Endocrinol (Lausanne) | 2026 | 41717550 | PubTator, text mining | PubMed |
| Higher serum follistatin levels are associated with increased vascular calcification in haemodialysis patients. | Front Endocrinol (Lausanne) | 2026 | 41710404 | PubTator, text mining | PubMed |
| Modelling adipose tissue-cancer crosstalk: a three-dimensional perspective. | Oncogene | 2026 | 41708953 | PubTator, text mining | PubMed |
| Adipo-Myokine Modulation in Obesity: Integrative Effects of Spinach Thylakoids and Functional Training in Men with Obesity: A Randomized Controlled Clinical Trial. | Nutrients | 2026 | 41683333 | PubTator, text mining | PubMed |
| Prediabetes Associates With Musculoskeletal Alterations Independent of Total Body Adiposity. | J Cachexia Sarcopenia Muscle | 2026 | 41612746 | PubTator, text mining | PubMed |
Lorcaserin induces abdominal fat loss with associated improvements of the circulating metabolome/lipidome and no changes in the myostatin-activin-follistatin-IGF-1 axes: A 6-month long randomized placebo-controlled clinical trial. | Diabetes Obes Metab | 2026 | 41574965 | PubTator, text mining | PubMed |
Effects of liraglutide treatment for 35-days on total and regional fat free, lean, and bone mass, and on the Myostatin-Activin-Follistatin-IGF-1 axes: a secondary analysis of a randomized placebo-controlled crossover study. | Diabetes Res Clin Pract | 2026 | 41571048 | PubTator, text mining | PubMed |
| Effect of exercise on hormonal responses in adolescents with obesity and leptin resistance: a randomized trial. | Sci Rep | 2026 | 41535443 | PubTator, text mining | PubMed |
| Exercise, Exerkines, and Sarcopenia. | Diabetes Metab J | 2026 | 41531287 | PubTator, text mining | PubMed |
| Frequently Reported Blood Biomarkers in Sarcopenia Clinical Trials: A Systematic Review and Meta-Analysis. | Aging Cell | 2026 | 41521726 | PubTator, text mining | PubMed |
| Comment on "Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin-activin-follistatin-IGF-1 axis". | Diabetes Obes Metab | 2026 | 41365837 | PubTator, text mining | PubMed |
| Mechanisms of Testosterone's Anabolic Effects on Muscle and Function: Controversies and New Insights. | Endocr Rev | 2026 | 41355050 | PubTator, text mining | PubMed |
| Myostatin, activin-A and follistatin are produced by the tumor in head and neck cancer and likely contribute to sarcopenia: A case-control, cross-sectional exploratory study. | Clin Nutr ESPEN | 2026 | 41338451 | PubTator, text mining | PubMed |
Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin-activin-follistatin-IGF-1 axis: Results from an exploratory, randomized, placebo-controlled, crossover study. | Diabetes Obes Metab | 2026 | 41287185 | PubTator, text mining | PubMed |
| High hyaluronan binding and RHAMM expression identify an invasive and metastatic subpopulation in androgen-resistant prostate cancer cells. | Matrix Biol | 2026 | 41271182 | PubTator, text mining | PubMed |
| Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure. | Hepatology | 2026 | 41183310 | PubTator, text mining | PubMed |
| Effect of an acute bout of endurance eccentric exercise on exerkines production in healthy males. | Eur J Appl Physiol | 2026 | 41102475 | PubTator, text mining | PubMed |
| Novel molecular biomarkers in kidney diseases: bridging the gap between early detection and clinical implementation. | J Pharm Pharmacol | 2026 | 41100213 | PubTator, text mining | PubMed |
| Impact of acute anorexia nervosa and of short-/long-term recovery after refeeding on the hormonal profiles of activin A, GDF-15 and follistatins. | Mol Psychiatry | 2026 | 40968258 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10468/papers?page=3